Completed PHASE4 INTERVENTIONAL 2-arm NCT01761136

The Safety and Immunogenicity of Haemophilus Influenzae Type b Vaccine in Different Injection Site

Phase 4 Study of Haemophilus Influenzae Type b Vaccine in Different Injection Site

Sponsor: Beijing Center for Disease Control and Prevention

Conditions Healthy

Interventions Inoculation in upper arm deltoid Inoculation in vastus lateralis muscle

Updated 5 times since 2017 Last updated: Mar 27, 2013 Started: Nov 30, 2011 Primary completion: Dec 31, 2012 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Healthy, this trial is completed. The trial is conducted by Beijing Center for Disease Control and Prevention and has accumulated 5 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Center for Disease Control and Prevention

Data source: Beijing Center for Disease Control and Prevention

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China